Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 51, 2021 - Issue 7
145
Views
4
CrossRef citations to date
0
Altmetric
Pharmacogenetics

Influence of UGT2B7 and UGT1A6 polymorphisms on plasma concentration to dose ratio of valproic acid in Chinese epileptic children

, , , , &
Pages 859-864 | Received 06 Apr 2021, Accepted 13 May 2021, Published online: 26 May 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xiao-Xiao Zheng, Yu-Xin You, Lin-Lin Zhao, Yan Du, Sheng-Qiu Xu & Dao-Quan Tang. (2023) EFfects of UGT1A, CYP2C9/19 and ABAT Polymorphisms on Plasma Concentration of Valproic Acid in Chinese Epilepsy Patients. Pharmacogenomics 24:3, pages 153-162.
Read now

Articles from other publishers (3)

E. V. Shreiner, A. I. Khavkin, M. S. Novikova, N. V. Kokh, M. Yu. Denisov & G. I. Lifshits. (2024) Assessment of the contribution of UGT1A gene polymorphisms to the development of cholelithiasis. Experimental and Clinical Gastroenterology:10, pages 133-138.
Crossref
Muhammad Saleh Faisal, Ayesha Jamil, Niaz Ali, Abdulrahman M. Alshahrani & Feras Almarshad. (2024) Distribution pattern of UGT1A6 and UGT2B7 gene polymorphism and its impact on the pharmacokinetics of valproic acid and carbamazepine: Prospective genetic association study conducted in Pakistani patients with epilepsy. Gene 892, pages 147886.
Crossref
Jun Matsumoto, Anzu Nishimoto, Shogo Watari, Hideo Ueki, Shoya Shiromizu, Naohiro Iwata, Tatsuaki Takeda, Soichiro Ushio, Makoto Kajizono, Masachika Fujiyoshi, Toshihiro Koyama, Motoo Araki, Koichiro Wada, Yoshito Zamami, Yasutomo Nasu & Noritaka Ariyoshi. (2022) Significance of UGT1A6, UGT1A9, and UGT2B7 genetic variants and their mRNA expression in the clinical outcome of renal cell carcinoma. Molecular and Cellular Biochemistry 478:8, pages 1779-1790.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.